# Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)

> **NCT02441933** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Yonsei University** · enrollment: 878 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** taxane plus carboplatin
- **DRUG:** Taxane

## Key facts

- **NCT ID:** NCT02441933
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-09-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 878 (ACTUAL)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02441933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02441933, "Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02441933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*